Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and rivaroxaban in lumbar posterior fixation fusion surgery
ChiCTR1800016430Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid and rivaroxaban in venous thromboembolism (VTE) (4 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Bleeding volume during operation, Bleeding volume after operation and 12 more. Started Jun 2018; status: recruiting.
02
Drugs
tranexamic acidrivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR1800016430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016430.